Dannaoui, E.
Publications
P295
Mycoses. 2025, 68, e70051
Antifungal Resistance in Non-fumigatus Aspergillus Species.
https://doi.org/10.1111/myc.70051
P286
J. Mycol. Med. 2024, 34, 101490.
Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).
https://doi.org/10.1016/j.mycmed.2024.101490
P243
Lancet Respir. Med. 2022, 10, 180-190.
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
https://doi.org/10.1016/S2213-2600(21)00442-2
P213
Clin. Infect. Dis. 2020, ciaa230.
Invasive aspergillosis due to Aspergillus section Usti: a European multi-centre study.
doi: 10.1093/cid/ciaa230
P190
J. Cyst. Fibros. 2019, 18, 212-220.
Prevalence, geographic risk factor, and development of standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study "MFIP".
doi: 10.1016/j.jcf.2018.10.001
P183
Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
doi : 10.1007/s11046-017-0162-4
P172
Mycoses 2018, 61, 30-34.
PCR-based detection of A. fumigatus and absence of azole resistance due to TR34/L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis.
doi: 10.1111/myc.12702
P147
Antimicrob. Agents Chemother. 2016, 60, 5088-5091.
Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.
doi: 10.1128/AAC.00630-16
Autres publications scientifiques
Brevets
Thèse